Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Amneal Pharmaceuticals Inc
(NY:
AMRX
)
5.180
USD
-0.210 (-3.90%)
Official Closing Price
Updated: 7:47 PM EST, Mar 1, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,290,600
Open
5.790
Bid (Size)
5.200 (1)
Ask (Size)
5.260 (5)
Prev. Close
5.390
Today's Range
5.150 - 5.840
52wk Range
2.400 - 6.180
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Amneal Receives Approval for Generic Version of Ortho Evra®
February 26, 2021
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration...
From
Business Wire News Releases
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
February 26, 2021
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the fourth quarter and full year ended December 31, 2020.
From
Business Wire News Releases
Performance
YTD
+6.15%
+6.15%
1 Month
+4.86%
+4.86%
3 Month
+31.14%
+31.14%
6 Month
+26.03%
+26.03%
1 Year
+30.15%
+30.15%
More News
Read More
908 Devices Appoints Jeff George and Fenel Eloi to its Board of Directors
February 23, 2021
From
Business Wire News Releases
Amneal to Virtually Participate at Upcoming Investor Conferences
February 22, 2021
From
Business Wire News Releases
Amneal to Report Fourth Quarter & Full Year 2020 Results on February 26, 2021
February 04, 2021
From
Business Wire News Releases
Recent Challenges Demand Innovative Approaches to Surface Disinfections
December 17, 2020
From
PR Newswire
Amneal to Acquire Substantially All of Kashiv Specialty Pharmaceuticals
January 12, 2021
From
Business Wire News Releases
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA
January 08, 2021
From
Business Wire News Releases
A Preview Of Amneal Pharmaceuticals's Earnings
February 25, 2021
Tags
Earnings
BZI/EP
Benzinga
From
Benzinga
Amneal to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021
From
Business Wire News Releases
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2020 Earnings Call Transcript
February 26, 2021
Tags
AMRX
Market News
From
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.